Tsumura & Co.

General ticker "TSMRF" information:

  • Sector: Health Care
  • Industry: Drug Manufacturers - Specialty & Generic
  • Capitalization: $1.8B (TTM average)

Tsumura & Co. does not follow the US Stock Market performance with the rate: -16.5%.

Estimated limits based on current volatility of 0.0%: low 23.20$, high 23.20$

Factors to consider:

  • Earnings expected soon, date: nan
  • Company pays dividends (annually): last record date 2026-03-31, amount 0.50$ (Y2.16%)
  • Earnings for 12 months up through Q4 are close to our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2025-03-31 to 2027-03-31

  • 2025-03-31 to 2026-03-31 estimated range: [20.62$, 32.20$]
  • 2026-03-31 to 2027-03-31 estimated range: [19.73$, 31.16$]

Financial Metrics affecting the TSMRF estimates:

  • Positive: with PPE of 10.2 at the end of fiscal year the price was neutral
  • Positive: 6.73 < Operating cash flow per share per price, % of 10.55
  • Positive: Operating profit margin, % of 22.16 > 18.65
  • Positive: Return on assets ratio (scaled to [-100,100]) of 6.53 > 6.08
  • Negative: 0.01 < Interest expense per share per price, % of 0.16
  • Negative: negative Industry operating cash flow (median)
  • Positive: Industry inventory ratio change (median), % of -0.92 <= -0.15
  • Negative: Investing cash flow per share per price, % of -7.79 <= -4.44
  • Negative: Industry earnings per price (median), % of 0 <= 0

Similar symbols

Short-term TSMRF quotes

Long-term TSMRF plot with estimates

Financial data

YTD 2023-03-31 2024-03-31 2025-03-31
Operating Revenue ¥140,043.00MM ¥150,845.00MM ¥181,093.00MM
Operating Expenses ¥119,127.00MM ¥130,828.00MM ¥140,968.00MM
Operating Income ¥20,916.00MM ¥20,017.00MM ¥40,125.00MM
Non-Operating Income ¥2,102.00MM ¥3,719.00MM ¥5,434.00MM
Interest Expense ¥256.00MM ¥330.00MM ¥518.00MM
R&D Expense ¥7,594.00MM ¥8,288.00MM ¥0.00MM
Income(Loss) ¥23,018.00MM ¥23,736.00MM ¥45,559.00MM
Taxes ¥5,632.00MM ¥5,689.00MM ¥11,035.00MM
Net Income(Loss)* ¥16,482.00MM ¥16,707.00MM ¥32,428.00MM
Stockholders Equity ¥252,045.00MM ¥270,801.00MM ¥300,528.00MM
Inventory ¥101,725.00MM ¥117,616.00MM ¥133,783.00MM
Assets ¥396,813.00MM ¥428,254.00MM ¥464,380.00MM
Operating Cash Flow ¥16,452.00MM ¥5,608.00MM ¥33,823.00MM
Capital expenditure ¥14,708.00MM ¥20,057.00MM ¥29,794.00MM
Investing Cash Flow ¥-15,493.00MM ¥-19,351.00MM ¥-24,974.00MM
Financing Cash Flow ¥24,423.00MM ¥-4,417.00MM ¥-19,871.00MM
Earnings Per Share** ¥215.63 ¥219.82 ¥427.15

* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.